Myosin storage myopathy

What it is, symptoms and effects

From: MedlinePlus Genetics, National Library of Medicine

Myosin storage myopathy is a condition that affects muscle (myopathy). This disorder causes muscle weakness that can worsen slowly over time. The signs and symptoms of myosin storage myopathy often begin in childhood, although they can begin later. The specific features of myosin storage myopathy and the severity of the condition can vary, even among members of the same family.

Children with myosin storage myopathy may start walking later than usual and have a waddling gait. They can have trouble climbing stairs and difficulty lifting their arms above shoulder level. Weak shoulder muscles often make the shoulder blades (scapulae) "stick out" from the back, a sign known as scapular winging. Affected individuals may also have a spine that curves to the side (scoliosis). Some individuals can also develop weakness of the muscles that control breathing (respiratory insufficiency) or weakness of the heart (cardiac) muscle.

Myosin storage myopathy belongs to a group of disorders called congenital myopathies. The signs and symptoms of congenital myopathies are often present at birth (congenital) or soon after. Congenital myopathies may affect the muscles used for movement (skeletal muscle) and, less commonly, the cardiac muscle.

Causes and biological mechanisms

From: MedlinePlus Genetics, National Library of Medicine

Genetic changes that cause disease are called pathogenic variants. Pathogenic variants in the MYH7 gene cause myosin storage myopathy. The MYH7 gene provides instructions for making a protein known as myosin-7. This protein is found in cardiac muscle and in certain skeletal muscle fibers.

Myosin-7 is the major component of the thick filament in muscle cell structures called sarcomeres. Sarcomeres are the basic units of muscle contraction. They are composed of overlapping thick and thin filaments that undergo cycles of attachment and release. These cycles allow the thin filaments to slide past the thick filaments, which shortens the sarcomere and causes the muscle to contract.

Pathogenic variants in the MYH7 gene can cause cells to produce a version of myosin-7 that does not function properly. The altered proteins accumulate within the skeletal muscle fibers, forming protein clumps that can be seen when muscle tissue is removed for examination (muscle biopsy). It is unclear exactly how these changes lead to the muscle weakness seen in people with myosin storage myopathy.

Inheritance and family implications

From: MedlinePlus Genetics, National Library of Medicine

Myosin storage myopathy is typically inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.

In rare cases, myosin storage myopathy has followed an autosomal recessive pattern, which means both copies of the gene in each cell must have a pathogenic variant to cause the disorder. The parents of an individual with an autosomal recessive condition each carry one copy of the altered gene, but they typically do not show signs and symptoms of the condition.

How common is it?

From: MedlinePlus Genetics, National Library of Medicine

Myosin storage myopathy is rare, although the exact number of people with this condition is unknown.

Understanding terms used in the source

These definitions explain medical words used above. A definition is not evidence that another condition is present, and it does not predict how a symptom will develop. Ask the clinician which terms apply to the actual examination or test result.

Scapular winging

Abnormal protrusion of the scapula away from the surface of the back.

Affected

This term applies to a family member who is diagnosed with the same condition as the individual who is the primary focus of investigation (the proband).

Myopathy

A disorder of muscle unrelated to impairment of innervation or neuromuscular junction.

Which doctor should you see?

The suggested department for discussing Myosin storage myopathy is Neurology, with a neurologist as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.

Additional services that may be relevant, depending on the findings, include: Clinical Genetics.

This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.

How to prepare for an assessment

Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.

Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.

• Which nervous-system findings help explain the symptoms?
• Would an assessment of walking, communication or daily function be helpful?
• Are rehabilitation or other specialist services relevant?

Treatment discussions and follow-up

The material gathered for this draft does not provide a complete condition-specific treatment pathway for Myosin storage myopathy. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.

Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.

The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.

When to seek emergency help

Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.